Breast cancer: How tumor cells break free and form metastases

When tumor cells acquire the capacity to move around and invade other tissues, there is a risk of metastases and cancer treatment becomes more difficult. At the Institut Curie, CNRS Director of Research Philippe Chavrier and his group have just discovered how breast cancer cells break the bonds that tether them to the tumor.

The basement membrane around the mammary gland is a barrier to the spread of cancer cells. Three proteins in the tumor cells transport enzymes needed to perforate this barrier, and another protein puts these enzymes in the right place.

These discoveries, published in the 16 June 2008 issue of The Journal of Cell Biology and in Current Biology on 8 July 2008, shed light on the early mechanisms of the formation of metastases in certain breast cancers. These findings constitute an essential step in the quest for the early identification of highly invasive tumors, or even the blocking of formation of metastases.

Tissues are generally formed by cells arranged side by side. Epithelial cells cover an outer surface, such as the skin or an organ such as the mammary gland, and remain tightly bound together. This cohesion is vital to the body’s functioning, and the epithelial cells remain in position in their original tissue until they die. Sometimes, though, they detach and move away, and while such migration is essential during embryonic development as cells give rise to new tissues, when tumor cells break loose this often heralds the formation of metastases.

When tumor cells break loose

Tumor cells accumulate errors, become totally anarchic, and flout all the rules. Some even become detached from the tumor through complex and poorly understood mechanisms. The Membrane and Cytoskeleton Dynamics Group headed by Philippe Chavrier (UMR 144 CNRS/Institut Curie) has now shed new light on the way cells, in this case breast cancer cells, escape their shackles. The mammary gland is separated from the neighboring tissue by the basement membrane, which the tumor cells will have to cross before continuing on their way.

The cell first forms protrusions called invadopodia and anchors them in the basement membrane. These “feet” provide everything needed to breach the membrane. The tumor cells produce a whole range of proteases that degrade the proteins of the extracellular matrix that hems them in, part of which is the basement membrane. These proteases cut a hole in the basement membrane through which the cells can escape.

In a first publication, the researchers used a model of metastatic breast cancer cells to show that the proteins sec3, sec8 and IQGAP1 transport vesicles containing proteases to the invadopodia. Without sec3, sec8 and IQGAP1 the vesicles cannot be fastened to the ends of the invadopodia and so the cells fail to escape into the neighboring tissue. Before the proteases can degrade the membrane, they must first be released from the vesicles.

In a second publication, Philippe Chavrier and colleagues show that the protein Vamp7 fuses protease-containing vesicles with the membrane of tumor cells. Only then can the proteases at the ends of the invadopodia progressively erode the basement membrane of the mammary gland. Inactivation of Vamp7 greatly reduces the ability of the breast cancer cells to degrade the extracellular matrix.

So tumor cells can only escape from the mammary gland by accomplishing a whole series of modifications. Philippe Chavrier and his group have shown how they hijack cellular mechanisms to leave their original tissue, after which they can spread throughout the body and form metastases.

These discoveries may help to explain why certain breast cancers are more aggressive than others, or even to identify highly invasive tumors at an early stage. It is also conceivable that tumor invasion could be blocked by acting on the underlying mechanisms identified by Philippe Chavrier and colleagues.

Source: Institut Curie

Related stories:

Researchers identify dangerous 'two-faced' protein crucial to breast cancer spread and growth
Two critical properties of cancer cells are their ability to divide without restraint and to spread away from the primary tumor to establish new tumor sites. Now, researchers from the Mayo Clinic campus in Florida have found a protein they say acts as a deadly master switch, both freeing cancer cells from a tumor while ramping up new growth.
Tiny sacs released by brain tumor cells carry information that may guide treatment
Microvesicles – tiny membrane-covered sacs – released from glioblastoma cells contain molecules that may provide data that can guide treatment of the deadly brain tumor. In their report in the December 2008 Nature Cell Biology, which is receiving early online release, Massachusetts General Hospital (MGH) researchers describe finding tumor-associated RNA and proteins in membrane microvesicles called exosomes in blood samples from glioblastoma patients. Detailed analysis of exosome contents identified factors that could facilitate a tumor's growth through delivery of genetic information or proteins, or signify its vulnerability to particular medications.
Metastatic movements in 3-D
Caswell et al.report in the Journal of Cell Biology how the altered behavior of integrins can prompt metastatic movement in tumor cells.
First glimpse of a key DNA repair protein at work
Repairing breaks in the two strands of the DNA double helix is critical for avoiding cancer. In humans and other organisms, a molecular machine called the MRN complex is responsible for finding and signaling double-strand breaks (DSBs), then launching the error-free method of DNA repair called homologous recombination.
Scientists deliver toxic genes to effectively kill pancreatic cancer cells
A research team, led by investigators at the Department of Surgery at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has achieved a substantial "kill" of pancreatic cancer cells by using nanoparticles to successfully deliver a deadly diphtheria toxin gene. The findings – set to be published in the October issue of Cancer Biology & Therapy – reflect the first time this unique strategy has been tested in pancreatic cancer cells, and the success seen offers promise for future pre-clinical animal studies, and possibly, a new clinical approach.
Muscle stem cell identity confirmed by Stanford researchers
A single cell can repopulate damaged skeletal muscle in mice, say scientists at the Stanford University School of Medicine, who devised a way to track the cell's fate in living animals. The research is the first to confirm that so-called satellite cells encircling muscle fibers harbor an elusive muscle stem cell.
Pores open the door to death
(PhysOrg.com) -- Our body is almost constantly being threatened by pathogens and cancerous cells that appear out of the blue. But the body puts up a fight: specialized cells in the immune system smuggle small molecules (granzymes) into cancer cells and those body cells that have fallen prey to viruses. The molecules then trigger off the diseased cells' built-in suicide program. There are two possible ways in which the granzymes gain entry into the cells under attack.
Novel structure proteins could play a role in apoptosis
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.